Lakefront Biotherapeutics NV current report, Q4 FY2018

Business Context and Reporting Period

This Form 6-K filing is submitted by Galapagos NV (not Lakefront Biotherapeutics NV as indicated in metadata) for the month of October 2018. The registrant is a foreign private issuer incorporated in Belgium, with its principal executive office in Mechelen. The filing primarily serves to incorporate by reference a press release dated October 31, 2018 (Exhibit 99.1), into the company's existing Registration Statements on Forms F-3 and S-8.

Key Financial Metrics

The provided filing text does not contain specific financial data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity within this document. The filing acts as a conduit for a press release rather than a financial statement.

Material Changes

The filing text does not disclose specific material changes in financial position or operations. It references a press release (Exhibit 99.1) which likely contains the material event, but the content of that release is not included in the provided text.

Guidance, Outlook, and Risks

No guidance, outlook, management commentary, or specific risk factors are detailed in the provided text. The document notes that the press release is incorporated by reference, except for a specific quote by Dr. Piet Wigerinck, but does not summarize the substance of that release.

Investor Verification Checklist

  • Verify the actual content of the press release dated October 31, 2018 (Exhibit 99.1), as the filing text only references it.
  • Confirm the identity of the registrant as Galapagos NV, noting the discrepancy with the "Lakefront Biotherapeutics NV" label in the request metadata.
  • Review the incorporated Registration Statements (Forms F-3 and S-8) for context on the press release's impact on capital raising or securities offerings.
  • Check for the specific quote by Dr. Piet Wigerinck mentioned as excluded from incorporation by reference.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.